Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$25,975,797
+$849,321 QoQ
Shares Held
102,279
-0.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#640
of 4,664 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,975,797 | 102,279 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $25,126,476 | 102,792 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $17,004,874 | 82,169 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,570,614 | 89,368 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,361,293 | 80,925 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $8,615,433 | 53,162 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,711,667 | 45,920 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,557,372 | 35,131 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,886,837 | 18,418 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,396,751 | 21,809 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,327,283 | 20,102 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,901,230 | 12,266 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,064,685 | 11,688 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,812,642 | 11,096 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,093,730 | 11,795 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,061,076 | 5,987 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $767,420 | 4,486 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $704,463 | 4,362 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $482,688 | 2,930 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $614,175 | 3,737 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $642,267 | 4,081 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $922,609 | 6,197 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $491,923 | 3,498 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $321,924 | 2,455 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||